To blind or not to blind first in human and exploratory clinical trials: Acceleration of development vs. risk of bias.
- DOI
- 10.1111/cts.13200
- Published
- 2022 Mar
- Container
- Clinical and translational science
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1111/cts.13200,
title = {To blind or not to blind first in human and exploratory clinical trials: Acceleration of development vs. risk of bias.},
author = {Haertter S and Kanodia J and Cook J and Alicea J and Brennan BJ and Desai A and Patel B and Pan L and Goteti K},
year = {2022},
journal = {Clinical and translational science},
doi = {10.1111/cts.13200},
url = {https://doi.org/10.1111/cts.13200}
}RIS
TY - JOUR TI - To blind or not to blind first in human and exploratory clinical trials: Acceleration of development vs. risk of bias. AU - Haertter S AU - Kanodia J AU - Cook J AU - Alicea J AU - Brennan BJ AU - Desai A AU - Patel B AU - Pan L AU - Goteti K PY - 2022 JO - Clinical and translational science DO - 10.1111/cts.13200 UR - https://doi.org/10.1111/cts.13200 ER -
APA
S, H., J, K., J, C., J, A., BJ, B., A, D., B, P., L, P., & K, G. (2022). To blind or not to blind first in human and exploratory clinical trials: Acceleration of development vs. risk of bias.. Clinical and translational science. https://doi.org/10.1111/cts.13200
Source records
- pubmed · retrieved 2026-09-26T23:29:22.089Z